Found 2071 matching trials
Immunotherapy of Melanoma Patients
PHASE1The purpose of this study is to test whether vaccination with antigenic pep...
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
PHASE2Researchers are evaluating the safety and effectiveness of a single adminis...
Location
Mayo Clinic in Rochester
Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™
PHASE4A study to investigate the incidence of influenza and influenza-related com...
Location
GSK Investigational Site
Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
NAThe purpose of this study is to determine how children with a history of se...
Location
University of California, Los Angeles
Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.
PHASE4This is a prospective, Open label randomized study. A total of 220 adults a...
Location
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University,
Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women
PHASE4The overall aim of this project is to evaluate the immunogenicity of TIV va...
Location
Nrf/Dst Vpd Rmpru
Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population
PHASE1Adopt the design of random, blind method and placebo to parallel control an...
Location
Multiple Locations
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
NARATIONALE: Flu vaccine may help the body build an immune response and decre...
Location
Hackensack University Medical Center
H3N2 M2SR in Pediatric Population
PHASE1This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Location
Saint Louis University - Center for Vaccine Development
Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
PHASE3Comparative trial of tolerability, reactogenicity, safety and immunogenicit...
Location
LLC "Energiya zdorov'ya"